The Patent Finder

Cenes Pharmaceuticals, Inc.

Also on record
Records under this name other than patents Cenes Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Cenes Pharmaceuticals, Inc.

PatentTitleStatus Expires Confidence
US 7,384,756Methods for treating muscle diseases and disorders
Formerly held
Term ended
Term ended Jun 10, 2025 · From the USPTO record
Term endedTerm ended Jun 10, 2025From the USPTO record
US 7,285,531Method for prophylaxis or treatment of a nervous system, pathophysiological condition involving a glial growth factor sensitive cell by administration of a glial growth factor
Formerly held
Term ended
Term ended Oct 23, 2024 · From the USPTO record
Term endedTerm ended Oct 23, 2024From the USPTO record
US 7,135,456Glial mitogenic factors, their preparation and use
Formerly held
Term ended
Term ended Nov 14, 2023 · From the USPTO record
Term endedTerm ended Nov 14, 2023From the USPTO record
US 7,115,554Methods of increasing myotube formation or survival or muscle cell mitogenesis differentiation or survival using neuregulin GGF III
Formerly held
Term ended
Term ended Oct 3, 2023 · From the USPTO record
Term endedTerm ended Oct 3, 2023From the USPTO record
US 7,037,888Methods for treating muscle diseases and disorders
Formerly held
Term ended
Ended no later than May 2, 2023 · From the USPTO record
Term endedEnded no later than May 2, 2023From the USPTO record
US 7,662,772Methods for treating congestive heart failure
Formerly held
Term ended
Term ended Aug 3, 2021 · From the USPTO record
Term endedTerm ended Aug 3, 2021From the USPTO record
US 10,717,775Methods for Cardiomyocyte Survival,proliferation or Differentiation by NRG-2
Formerly held
Term ended
Term ended May 23, 2021 · High confidence
Term endedTerm ended May 23, 2021High confidence
US 10,232,016Methods for Treating Congestive Heart Failure
Formerly held
Term ended
Ended no later than Nov 27, 2019 · Low confidence
Term endedEnded no later than Nov 27, 2019Low confidence
US 6,444,642Methods of increasing myotube formation or survival or muscle cell mitogenesis, differentiation or survival using a neuregulin
Formerly held
Term ended
Ended no later than Sep 3, 2019 · From the USPTO record
Term endedEnded no later than Sep 3, 2019From the USPTO record
US 6,635,249Methods for treating congestive heart failure
Formerly held
Term ended
Term ended Apr 23, 2019 · From the USPTO record
Term endedTerm ended Apr 23, 2019From the USPTO record
10 of 72 patents shown.
Pro members see all 72.
Pro members: see all 72 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited